Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a combination study of BMS-790052 and BMS-650032 in Japanese subjects with genotype 1 chronic hepatitis C
jRCT2080221067Phase 2
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of daclatasvir and asunaprevir in hepatitis C virus infection, sponsored by Bristol Myers Squibb.
02
Drugs
daclatasvirasunaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on jRCT2080221067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221067.